These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 18846112
1. Therapy of head and neck squamous cell carcinoma with replicative adenovirus expressing tissue inhibitor of metalloproteinase-2 and chemoradiation. McNally LR, Rosenthal EL, Zhang W, Buchsbaum DJ. Cancer Gene Ther; 2009 Mar; 16(3):246-55. PubMed ID: 18846112 [Abstract] [Full Text] [Related]
2. In vivo efficacy of marimastat and chemoradiation in head and neck cancer xenografts. Skipper JB, McNally LR, Rosenthal EL, Wang W, Buchsbaum DJ. ORL J Otorhinolaryngol Relat Spec; 2009 Mar; 71(1):1-5. PubMed ID: 18931526 [Abstract] [Full Text] [Related]
3. Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa). Huang SM, Li J, Armstrong EA, Harari PM. Cancer Res; 2002 Aug 01; 62(15):4300-6. PubMed ID: 12154033 [Abstract] [Full Text] [Related]
4. Combined radiation sensitizing and anti-angiogenic effects of ionizing radiation and the protease inhibitor ritonavir in a head and neck carcinoma model. Maggiorella L, Wen B, Frascogna V, Opolon P, Bourhis J, Deutsch E. Anticancer Res; 2005 Aug 01; 25(6B):4357-62. PubMed ID: 16309240 [Abstract] [Full Text] [Related]
5. Antitumor effects of telomelysin in combination with paclitaxel or cisplatin on head and neck squamous cell carcinoma. Kondo N, Tsukuda M, Kimura M, Fujita K, Sakakibara A, Takahashi H, Ishiguro Y, Toth G, Matsuda H. Oncol Rep; 2010 Feb 01; 23(2):355-63. PubMed ID: 20043095 [Abstract] [Full Text] [Related]
6. HDAC inhibitor valproic acid enhances tumor cell kill in adenovirus-HSVtk mediated suicide gene therapy in HNSCC xenograft mouse model. Kothari V, Joshi G, Nama S, Somasundaram K, Mulherkar R. Int J Cancer; 2010 Feb 01; 126(3):733-42. PubMed ID: 19569045 [Abstract] [Full Text] [Related]
9. Vandetanib restores head and neck squamous cell carcinoma cells' sensitivity to cisplatin and radiation in vivo and in vitro. Sano D, Matsumoto F, Valdecanas DR, Zhao M, Molkentine DP, Takahashi Y, Hanna EY, Papadimitrakopoulou V, Heymach J, Milas L, Myers JN. Clin Cancer Res; 2011 Apr 01; 17(7):1815-27. PubMed ID: 21350000 [Abstract] [Full Text] [Related]
10. Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma. Jiang M, Liu Z, Xiang Y, Ma H, Liu S, Liu Y, Zheng D. BMC Cancer; 2011 Feb 03; 11():54. PubMed ID: 21291526 [Abstract] [Full Text] [Related]
11. Combination antiangiogenic therapy and radiation in head and neck cancers. Hsu HW, Wall NR, Hsueh CT, Kim S, Ferris RL, Chen CS, Mirshahidi S. Oral Oncol; 2014 Jan 03; 50(1):19-26. PubMed ID: 24269532 [Abstract] [Full Text] [Related]
12. The role of adenovirus-mediated retinoblastoma 94 in the treatment of head and neck cancer. Li D, Day KV, Yu S, Shi G, Liu S, Guo M, Xu Y, Sreedharan S, O'Malley BW. Cancer Res; 2002 Aug 15; 62(16):4637-44. PubMed ID: 12183420 [Abstract] [Full Text] [Related]
13. [Adenovirus-delivered tissue inhibitor of metalloproteinases-3 transfection increases the sensitivity of cervical cancer cells to cisplatin]. Zhang Y, Lin C, Qian HL, Lang JH, Fu M, Zhang XY, Liang X, Duan H, Xiang Y. Zhonghua Zhong Liu Za Zhi; 2007 Jan 15; 29(1):25-9. PubMed ID: 17575689 [Abstract] [Full Text] [Related]
14. Comparison of radiosensitizing effects of the mammalian target of rapamycin inhibitor CCI-779 to cisplatin in experimental models of head and neck squamous cell carcinoma. Ekshyyan O, Rong Y, Rong X, Pattani KM, Abreo F, Caldito G, Chang JK, Ampil F, Glass J, Nathan CO. Mol Cancer Ther; 2009 Aug 15; 8(8):2255-65. PubMed ID: 19625495 [Abstract] [Full Text] [Related]
15. Head and neck squamous cell carcinoma targeted chemosensitization. Figures MR, Wobb J, Araki K, Liu T, Xu L, Zhu H, O'Malley BW, Li D. Otolaryngol Head Neck Surg; 2009 Aug 15; 141(2):177-83. PubMed ID: 19643248 [Abstract] [Full Text] [Related]
16. Cytotoxic effects of the oncolytic herpes simplex virus HSV1716 alone and in combination with cisplatin in head and neck squamous cell carcinoma. Mace AT, Harrow SJ, Ganly I, Brown SM. Acta Otolaryngol; 2007 Aug 15; 127(8):880-7. PubMed ID: 17763002 [Abstract] [Full Text] [Related]
17. Retinoblastoma RB94 enhances radiation treatment of head and neck squamous cell carcinoma. Araki K, Ahmad SM, Li G, Bray DA, Saito K, Wang D, Wirtz U, Sreedharan S, O'Malley BW, Li D. Clin Cancer Res; 2008 Jun 01; 14(11):3514-9. PubMed ID: 18519784 [Abstract] [Full Text] [Related]
18. Combination of mutated herpes simplex virus type 1 (G207 virus) with radiation for the treatment of squamous cell carcinoma of the head and neck. Kim SH, Wong RJ, Kooby DA, Carew JF, Adusumilli PS, Patel SG, Shah JP, Fong Y. Eur J Cancer; 2005 Jan 01; 41(2):313-22. PubMed ID: 15661558 [Abstract] [Full Text] [Related]
19. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus. Khan Z, Khan AA, Prasad GB, Khan N, Tiwari RP, Bisen PS. Radiother Oncol; 2016 Feb 01; 118(2):359-68. PubMed ID: 26747757 [Abstract] [Full Text] [Related]
20. Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk. Morris JC, Wildner O. Mol Ther; 2000 Jan 01; 1(1):56-62. PubMed ID: 10933912 [Abstract] [Full Text] [Related] Page: [Next] [New Search]